AQR Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$286K Sell
2025
Q2
$269K Buy
2024
Q4
Sell
2024
Q3
$1.03M Buy
2022
Q2
Sell
2022
Q1
$85K Buy
2019
Q4
Sell
2019
Q3
$82K Sell
2019
Q2
$143K Sell
2019
Q1
$228K Hold
2018
Q4
$212K Hold
2018
Q3
$271K Buy
2018
Q2
$211K Buy